
Sign up to save your podcasts
Or


Dario Neri, co-founder and CEO of Philogen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Philogen is working to discover and develop targeted therapies to treat cancer and chronic inflammation.
By John Simboli5
77 ratings
Dario Neri, co-founder and CEO of Philogen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Philogen is working to discover and develop targeted therapies to treat cancer and chronic inflammation.

3,062 Listeners

1,938 Listeners

1,094 Listeners

2,362 Listeners

946 Listeners

793 Listeners

123 Listeners

321 Listeners

6,066 Listeners

94 Listeners

10,024 Listeners

518 Listeners

153 Listeners

249 Listeners

182 Listeners